On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults with Isolated Systolic Hypertension

Hypertension

Volumn 69, Issue 2, 2017, Pages 220-227

  Yano, Yuichiro ^a,b   Rakugi, Hiromi ^c   Bakris, George L ^d   Lloyd Jones, Donald M ^b   Oparil, Suzanne ^e   Saruta, Takao ^f   Shimada, Kazuyuki ^g   Matsuoka, Hiroaki ^h   Imai, Yutaka ⁱ   Ogihara, Toshio ^c,j  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Section of Endocrinology Diabetes and Metabolism   (United States)

^e University of Alabama at Birmingham   (United States)

^f KEIO UNIVERSITY   (Japan)

^g Shin Oyama City Hospital   (Japan)

^h DOKKYO MEDICAL UNIVERSITY   (Japan)

ⁱ TOHOKU UNIVERSITY   (Japan)

^j MORINOMIYA UNIVERSITY OF MEDICAL SCIENCES   (Japan)

more..

Author keywords

blood pressure; cardiovascular diseases; elderly; hypertension; mortality; U shaped relationship

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VALSARTAN; ANTIHYPERTENSIVE AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE (PEOPLE); KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; VASCULAR DISEASE; BLOOD PRESSURE MEASUREMENT; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECTS; EPIDEMIOLOGY; FOLLOW UP; HYPERTENSION; JAPAN; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SYSTOLE; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; JAPAN; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SYSTOLE;

EID: 85008352196     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08600     Document Type: Article

References (30)

1. United Nations. World Population Prospects: The 2010 Revision. Available at: http://esa.un.org/unpd/wpp. Accessed December 20, 2016.
2. Aronow WS, Fleg JL, Pepine CJ, ACCF Task Force ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011 123 2434 2506. doi: 10.1161/CIR.0b013e31821daaf6.
3. Benetos A, Bulpitt CJ, Petrovic M, Ungar A, Agabiti Rosei E, Cherubini A, Redon J, Grodzicki T, Dominiczak A, Strandberg T, Mancia G, An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects. Hypertension 2016 67 820 825. doi: 10.1161/HYPERTENSIONAHA.115.07020.
4. Fagard RH, Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 2002 11 23 28
5. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D, Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995 25 305 313
6. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D, Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997 96 308 315
7. Safar ME, Arterial aging-hemodynamic changes and therapeutic options. Nat Rev Cardiol 2010 7 442 449. doi: 10.1038/nrcardio.2010.96.
8. Qureshi AI, Suri MF, Mohammad Y, Guterman LR, Hopkins LN, Isolated and borderline isolated systolic hypertension relative to long-Term risk and type of stroke: A 20-year follow-up of the national health and nutrition survey. Stroke 2002 33 2781 2788
9. Antikainen R, Jousilahti P, Tuomilehto J, Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-Aged population. J Hypertens 1998 16 577 583
10. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J, Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol 2002 13 2776 2782
11. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H, Valsartan in Elderly Isolated Systolic Hypertension Study Group Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010 56 196 202. doi: 10.1161/HYPERTENSIONAHA.109.146035.
12. Ogihara T, Saruta T, Matsuoka H, Shimamoto K, Fujita T, Shimada K, Imai Y, Nishigaki M, valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design. Hypertens Res 2004 27 657 661
13. Saruta T, The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004) Nihon Rinsho 2005 63 952 958
14. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, Pepine CJ, Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010 304 61 68. doi: 10.1001/jama.2010.884.
15. Mancia G, Kjeldsen SE, Zappe DH, Holzhauer B, Hua TA, Zanchetti A, Julius S, Weber MA, Cardiovascular outcomes at different on-Treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J 2016 37 955 964. doi: 10.1093/eurheartj/ehv633.
16. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008 117 743 753. doi: 10.1161/CIRCULATIONAHA.107.699579.
17. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991 265 3255 3264
18. Staessen JA, Fagard R, Thijs L, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997 350 757 764
19. Liu L, Wang JG, Gong L, Liu G, Staessen JA, Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998 16 12 pt 1 1823 1829
20. James PA, Oparil S, Carter BL, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427.
21. Xie X, Atkins E, Lv J, Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-Analysis. Lancet 2016 387 435 443. doi: 10.1016/S0140-6736(15)00805-3.
22. Wright JT Jr, Williamson JD, Whelton PK, A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015 373 2103 2116
23. Williamson JD, Supiano MA, Applegate WB, SPRINT Research Group Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: A randomized clinical trial. JAMA 2016 315 2673 2682. doi: 10.1001/jama.2016.7050.
24. Bakris GL, The implications of blood pressure measurement methods on treatment targets for blood pressure. Circulation 2016 134 904 905. doi: 10.1161/CIRCULATIONAHA.116.022536.
25. Systolic Blood Pressure Intervention Trial (SPRINT). https://clinicaltrials.gov/ct2/show/NCT01206062. Accessed November 1, 2016
26. Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB, The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999 159 2004 2009
27. Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, de Leeuw PW, Leonetti G, Tuomilehto J, Yodfat Y, On-Treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007 167 1884 1891. doi: 10.1001/archinte.167.17.1884.
28. Fujiyoshi A, Miura K, Ohkubo T, Kadowaki T, Kadowaki S, Zaid M, Hisamatsu T, Sekikawa A, Budoff MJ, Liu K, Ueshima H, SESSA Research Group; MESA Research Group Cross-sectional comparison of coronary artery calcium scores between Caucasian men in the United States and Japanese men in Japan: The multi-ethnic study of atherosclerosis and the Shiga epidemiological study of subclinical atherosclerosis. Am J Epidemiol 2014 180 590 598. doi: 10.1093/aje/kwu169.
29. Tanna MS, Bangalore S, Antihypertensive therapy and the J-curve: fact or fiction? Curr Hypertens Rep 2015 17 6. doi: 10.1007/s11906-014-0516-y.
30. Odden MC, McClure LA, Sawaya BP, White CL, Peralta CA, Field TS, Hart RG, Benavente OR, Pergola PE, Achieved blood pressure and outcomes in the secondary prevention of Small Subcortical Strokes Trial. Hypertension 2016 67 63 69. doi: 10.1161/HYPERTENSIONAHA.115.06480.